CIK 0001478320 · Large accelerated filer
Adaptive Biotechnologies Corp
Sign in to watch- Ticker
- ADPT
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- WA
- Entity type
- operating
- EIN
- 270907024
- Phone
- 206-659-0067
- Business address
- 1165 EASTLAKE AVE E, SEATTLE, WA, 98109
- Former names
- Adaptive TCR Corp
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 4 Option exercise Director acquired 53,000 shares (option exercise)
- 4 Open-market sale Chief Operating Officer sold 3,125 shares at an average $8.55 ($26,733)
- 4/A Open-market sale Principal Accounting Officer sold 307 shares at $8.87 ($2,723)
- 4 Open-market sale Principal Accounting Officer sold 959 shares at $8.87 ($8,506)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Commercial Officer, MRD sold 31,066 shares at $8.00 ($248,528)
- 4 Open-market sale Chief Operating Officer sold 3,125 shares at an average $7.26 ($22,685)
- SC 13G/A Stake Amended Statement of Ownership
- 8-K Event Material agreement · New debt or obligation · Other events
- 4 Open-market sale Chief Commercial Officer, MRD sold 17,540 shares at $10.98 ($192,589)
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Open-market sale Chief Operating Officer sold 3,125 shares at an average $10.22 ($31,943)
- 8-K Event Shareholder vote results
- 4 Grant or award Chief Financial Officer acquired 374,688 shares (grant or award)
- 3 Insider Initial Statement of Ownership
Page 18 of 42 · 837 filings